Introduction
============

Docking is a method which predicts the preferred orientation of one molecule to a second when bound to each other to form a stable complex ([@B1]). Docking is frequently used to predict the binding orientation of small molecule drug candidates to their protein targets in order to in turn predict the affinity and activity of the small molecule. Hence docking plays an important role in the rational design of drugs ([@B2]). Given the biological and pharmaceutical significance of molecular docking, considerable efforts have been directed towards improving the methods used to predict docking.

Two approaches are generally used for docking calculations. One approach uses a matching technique that describes the protein and the ligand as complementary surfaces ([@B3]). The second approach simulates the actual docking process in which the ligand-protein pairwise interaction energies are calculated ([@B4]).

In geometric matching the protein and ligand are described as sets of features that enable them to be docked. In one method receptor's surface is described in terms of solvent accessible surface area and the ligand's molecular surface is described in terms of matching surface description. Another method is to describe hydrophobic features of the protein using turns in main chain atoms. Yet another approach is to use a Fourier shape descriptor technique ([@B5], [@B6]).

The simulation of docking is a much more complicated process. In this method ligand and receptor are positioned in a distance and the ligand is let to find its way into the active site with certain number of moves. The moves incorporate rigid body transformations such as translations and rotations.

After each move total energy of the system is calculated.

The Artificial neural network (ANN) analysis is a method of data analysis, which imitates the human brain's way of working. The power of ANN~s~ has been shown over the years by their successful use in many types of problems with different degrees of complexity and in different fields of application. Neural networks represent the way in which arrays of neurons probably function in biological learning and memory ([@B7]). These networks are known as the universal approximations and computational models with particular characteristics such as the ability to learn or adapt, to organize or to generalize data. The learning of ANNs takes place by training with examples, "in a process that uses a training algorithm to iteratively adjust the connection weights between neurons to produce the desired input--output relationships" ([@B8]). It has been widely used in optimization, calibration, modeling and pattern recognition. ANNs are very useful in medical and pharmaceutical sciences, for example in diagnosis of diseases (). Also ANNs have shown a good potential in calculation of physic-chemical and biological properties of drugs with more attention to pharmaceutical and chemical areas ([@B12]). In recent years many studies have been done in this field. Agatonovic-Kustrin and Beresford ([@B13]) reviewed the pharmaceutical applications of ANN method. ANN has been used to calculate aqueous solubility of drugs employing a number of molecular descriptors ([@B14]), and in other situations ([@B15]-[@B18]).

It is proposed that by using artificial neural networks a set of descriptors can be incorporated to predict binding energy of final docking complex to facilitate and speed up screening processes.

The aim of this study was to design and test the appropriate ANN, which could allow predicting binding energy on basis of structural descriptors describing the structure of the selected basic drugs.

Materials and Methods
=====================

*Structural parameters from molecular modeling*

Descriptors of the structure of drugs were calculated by standard molecular modeling. Hyperchem® Ver. 8.5 for Windows® operating system was used. Geometry optimization was performed using molecular mechanics MM+ force field method and was followed by quantum chemical calculations according to semi-empirical AM1 method. Moreover, the set of structural descriptors was supplemented with Dragon Ver 4.5 software. The list of descriptors is presented in [Table 3](#T3){ref-type="table"}.

*Docking*

Autodock Ver 4.2 on Ubuntu Linux platform was used for docking. MGL tools Ver 1.5.4 was used for preparation and conversion of structures in Linux. COX2 (PDB ID: 6COX) was used as macromolecule and was set to rigid. The grid box was created with default 40x40x40 dots, each dot being 0.375Å, and was centered in the active site of the protein guided by presence of Celecoxib in original file. Number of general algorithm (GA) runs was set to twenty and the best result of each set with lowest binding energy was chosen. Structures were finally observed and examined using Swiss PDB Viewer Ver 4.0.4 and ViewerLite 4.2 in Windows 7.

*Artificial neural network (ANN) analysis*

An ANN involves the nodes that are known as neurons. The neurons are structured into a sequence of layers and connected to each other by using variable connection weights ([@B12]). Each layer can have a number of different neurons with various transfer functions ([@B19]). The first layer is the input layer with 27 nodes. The last layer is the output layer consisting of one node and a hidden layer containing 4 nodes is placed between input and output layers, where all three layers are responsible for learning process of the network.

The data were divided randomly into three groups. The first group was considered for training with 23 compounds. The second group was used for validation containing 5 compounds and testing set with 5 compounds. At the end of the training process, it is necessary to evaluate the capability of ANN model in prediction of other data. The validation set is used to monitor the performance of the model during the training phase and to minimize over fitting. Finally the test set is used to evaluate the trained neural network.

The input vector presented to an ANN is normalized between 0 and 1.

We used the multi-layer perceptron (MLP) network models with back propagation in which weighted sum of inputs and bias term are passed to the activation level through the transfer function to produce the output. Transfer functions can take any form and may be linear or non-linear ([@B20]). In this study transfer function in the first layer is the 'S' shaped logistic sigmoid whose general form is given as   and transfer function in the second layer is linear. In this structure, functions can be well approximated. Back-propagation algorithm based on MATLAB's Neural Network Toolbox was used for ANN training. In this method, the output response is compared to a desired target response; if the actual response differs from the target response, the network generates an error signal, which is then used to calculate the adjustments that should be made to correct parameter weights, so that the actual output matches the target output. This algorithm is intended to change the weights until the error between output (predicted data) and target (docking data) is minimized.

![Architecture of artificial neural network predicting binding energy on the basis of selected structural descriptors. Artificial Neural Networks model type: MLP 27-4- 1](ijbms-16-1196-g001){#F1}
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Learning was completed in 150 epochs by back propagation method. In order to decrease the sensitivity predicted results by ANN, to displacement of compounds in different sets; this experiment was done 40 times with diverse selections from training, validation and test data sets.

[Figure 1](#F1){ref-type="fig"} represents the architecture of the ANN model used for predictions of binding energy.

Results
=======

The list of values of the structural parameters of the drugs studied derived from calculation chemistry, reflecting their electronic properties, size (bulkiness), lipophilicity and other 2D and 3D parameters are summarized in [Table 4](#T4){ref-type="table"}.

[Table 3](#T3){ref-type="table"} as [Figure 1](#F1){ref-type="fig"} shows; we have 27 neurons in the input layer, 4 neurons in hidden layer and 1 neuron in the output layer. Thus the final model possessed a 27-4-1 architecture.

An ANN model was used to correlate binding energy behavior of the set of structurally diverse drugs with their structural descriptors and to create a model useful to prediction of binding energy.

Regression R values measure the correlation between outputs and targets. An R value of 1 means a close relationship while 0 means a random relationship. In [Table 1](#T1){ref-type="table"} the correlation coefficients between experimented outputs and predicated outputs are presented. These results are the averages of 40 iterations for each set.

A correlation between docking and ANN binding energy values in learning, validating and testing set is given in [Figure 2](#F2){ref-type="fig"}.

Discussion
==========

Results show that Autodock and ANN data have a high correlation. As seen in [Table 1](#T1){ref-type="table"}, the accuracy of the results increases with augmentation of hidden layer nodes. On the other hand, we achieved a good result and there was no need to increase neurons in hidden layer. Thus model 27-4-1 is a good structure.

[Table 2](#T2){ref-type="table"} shows the information about errors between target and output.

###### 

The standard Pearson-R correlation coefficient between the target and actual output values

  Number of neurons in hidden layer   Learning set   Validation set   Testing set
  ----------------------------------- -------------- ---------------- -------------
  2                                   0.940          0.902            0.845
  3                                   0.973          0.952            0.930
  4                                   0.973          0.956            0.950

###### 

Statistics of Artificial Neural Networks processing used during the study with 4 neurons in hidden layer

  Statistics      Learning set   Validation set   Testing set
  --------------- -------------- ---------------- -------------
  Error meana     0.01           0.029            0.053
  Error SDb       0.1            0.21             0.3
  Abs E Mean~c~   0.095          0.19             0.241
                                                  

Average error of the output variableStandard deviation of errors for the output variableAverage absolute error (difference between target and output values) of the output variable

###### 

List of structural parameters employed in ANN analysis

  ----------------------------------------------------------------------------------------------------------------
  Abbreviation   Description
  -------------- -------------------------------------------------------------------------------------------------
  MW             Molecular weight

  Sv             Sum of van der waals volumes C

  ISIZ           Information index on molecular size

  ZM1            Zagreb m1 index

  ZM2            Zagreb m2 index

  Qindex         Quadratic index

  Pol            Polarity number

  TWC            Total walk count

  GGI1           Topological charge index

  ATS1m          Broto-Moreau autocorecction of a topological structure lag one\
                 weighted by atomic mass

  ATS1v          Broto-Moreau autocorecction of a topological structure lag one weighted by atomic van der waals

  AROM           Aromaticity

  AGDD           Averagegeometric distance degree

  MAXDN          Maximal electrotopologicalnegative variation

  MAXDP          Maximal electrotopological positive variation

  MEV            Molecularelectrotopological variation

  SPH            Spherosity

  ASP            Asphericity

  FDI            Folding degree index

  Tu             Total size index

  ITH            Total information index on leverage content

  Ui             Unsaturation index

  Hy             Hydrophilic factor

  ARR            Aromatic ratio

  MR             Molarrefractivity

  PSA            Polar surface area

  MLOGP          LogP

  BE             BindingEnergy (KCal.mol^-1^)
  ----------------------------------------------------------------------------------------------------------------

###### 

List of drugs studied, binding energy values and structural parameters

  Name               MW       Sv      ISIZ      ZM1   ZM2   Qindex   Pol   TWC     GGI1   ATS1m   ATS1v   AROM      AGDD      MAXDN   MAXDP
  ------------------ -------- ------- --------- ----- ----- -------- ----- ------- ------ ------- ------- --------- --------- ------- -------
  Acetaminophen      151.18   12.41   86.439    50    53    6        11    70.3    3      0.64    0.593   0.987     70.162    1.782   3.524
  Aspirin            180.17   13.44   92.239    60    66    7        16    86.9    3      0.732   0.61    0.922     79.012    2.781   3.612
  Benoxaprofen       301.74   22.85   166.465   112   132   17       32    170     5      0.79    0.683   0.925     179.753   2.532   4.038
  Celecoxib          381.41   26.61   212.877   142   166   22       41    215.6   8.5    0.969   0.661   0.954     215.823   5.856   5.125
  Diclofenac         296.16   21.08   147.207   94    107   12       27    139.2   4      0.834   0.695   0.984     133.622   2.556   3.827
  Diflunisal         250.21   17.75   122.211   92    107   13       28    138.3   4.5    0.811   0.684   0.942     113.926   2.989   5.52
  Dup697             411.33   25.58   179.525   124   145   19       35    187.9   6.5    1.19    0.753   0.954     173.698   4.128   5.124
  Etodolac           287.39   25.51   226.477   114   140   18       38    181.1   5      0.602   0.602   0.949     195.592   2.487   4.286
  Etoricoxib         358.87   27.02   206.131   128   149   19       38    193.1   6.5    0.935   0.697   0.883     198.474   4.145   4.613
  Fenoprofen         242.29   20.72   160       88    99    11       24    128.7   3.5    0.653   0.639   0.997     149.165   2.508   3.929
  Flurbiprofen       244.28   20.32   153.58    90    104   12       27    134.4   3.5    0.668   0.662   0.962     138.997   2.583   5.772
  Ibuprofen          206.31   19.4    166.465   70    77    8        19    100.9   4      0.521   0.584   0.997     151.669   2.438   3.762
  Indomethacin       357.81   27.56   219.66    132   158   19       42    204.5   5.5    0.755   0.658   0.91      213.115   2.621   5.987
  Ketoprofen         254.3    21.72   166.465   94    108   12       28    139.6   3.5    0.653   0.664   0.898     147.718   2.565   5.244
  Ketorolac          211.28   19.09   140.881   86    103   14       22    132.2   2      0.643   0.661   0.901     131.146   1.534   5.246
  Lumiracoxib        293.74   22.05   166.465   100   114   13       29    148.4   5      0.755   0.662   0.978     149.781   2.613   5.746
  Meclofenamicacid   296.16   21.08   147.207   96    112   13       30    144.5   4      0.834   0.695   0.946     138.029   2.678   4.143
  Mefenamicacid      241.31   21.2    166.465   90    104   12       27    134.3   3.5    0.626   0.637   0.944     151.165   2.594   4.124
  Meloxicam          351.44   24.19   186.117   126   153   20       41    197.2   6      1.054   0.657   -38.108   176.489   4.814   5.509
  Nabumetone         228.31   20.81   166.465   84    95    11       23    123.8   4      0.598   0.627   0.94      169.217   1.431   3.948
  Naproxen           230.28   19.72   153.58    86    100   12       26    129.1   4      0.642   0.628   0.94      144.755   2.474   3.916
  Nimesulide         310.36   22.22   179.525   106   118   14       28    155.1   6      0.951   0.608   0.63      172.156   4.41    4.348
  NS-398             316.42   24.02   219.66    106   118   14       28    155.1   6      0.828   0.564   0.989     204.15    4.359   4.388
  Oxaprozin          293.34   24.71   192.75    112   129   15       30    167.9   3.5    0.691   0.661   0.966     197.506   2.527   3.735
  Parecoxib          370.46   28.91   240.215   136   160   19       41    207.2   6      0.869   0.653   0.91      249.029   4.785   5.192
  Piroxicam          331.38   24.11   186.117   124   150   19       42    193.4   5      0.966   0.653   0.811     188.417   4.823   5.502
  Rofecoxib          314.38   24.32   186.117   118   139   18       34    179.8   5      0.911   0.684   0.886     179.386   4.15    5.009
  Sulindac           356.44   28.11   226.477   132   156   19       40    202.2   6      0.809   0.684   0.826     231.474   2.611   5.656
  Suprofen           260.33   20.21   147.207   90    104   12       25    133.9   3.5    0.786   0.682   0.894     140.782   2.535   5.017
  Tolmetin           257.31   21.71   172.974   96    111   13       27    143.8   4.5    0.651   0.627   0.899     172.356   2.574   5.309
  Valdecoxib         314.39   24.2    186.117   118   139   18       34    179.8   5      0.925   0.672   0.911     178.467   4.617   4.333
  Zileuton           222.34   18.17   140.881   76    87    11       19    113.2   3.5    0.713   0.623   0.685     123.078   2.134   3.728
  Zomepirac          243.28   20.12   153.58    92    109   13       28    140.7   3.5    0.676   0.636   0.887     138.427   2.701   5.31

Conclusion
==========

In present study, a set of 27 descriptors is adopted to build a model to describe docking energy of 33 drugs of diverse chemical structure with antagonistic effects on COX2 enzyme. We built a structure using neural networks which predicts binding energy and developed a multi-layer perceptron artificial neural network (ANN) model, which has been trained by back propagation algorithm. Results show that docking results and ANN data have a high correlation. As presented in [Table 1](#T1){ref-type="table"}, correlation coefficients for learning, validating and testing sets equaled 0.973, 0.956 and 0.95, respectively. Also the error between the autodock results and ANN data was good. It was shown that ANN is a strong tool for prediction of the binding energy and thus inhibition constants for different drugs in very short period to minimize the amount of time used in virtual screening techniques.
